Suppr超能文献

改良版晚期肺癌炎症指数(ALI)在小细胞肺癌患者中的预后意义:与原始ALI的比较

Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.

作者信息

Kim Eun Young, Kim Nambeom, Kim Young Saing, Seo Ja-Young, Park Inkeun, Ahn Hee Kyung, Jeong Yu Mi, Kim Jeong Ho

机构信息

Department of Radiology, Gachon University Gil Medical Center, Incheon, Republic of Korea.

Neuroscience Research Institute, Gachon University, Incheon, Republic of Korea.

出版信息

PLoS One. 2016 Oct 5;11(10):e0164056. doi: 10.1371/journal.pone.0164056. eCollection 2016.

Abstract

BACKGROUND

Advanced lung cancer inflammation index (ALI, body mass index [BMI] x serum albumin/neutrophil-lymphocyte ratio [NLR]) has been shown to predict overall survival (OS) in small cell lung cancer (SCLC). CT enables skeletal muscle to be quantified, whereas BMI cannot accurately reflect body composition. The purpose was to evaluate prognostic value of modified ALI (mALI) using CT-determined L3 muscle index (L3MI, muscle area at L3/height2) beyond original ALI.

METHODS

L3MIs were calculated using the CT images of 186 consecutive patients with SCLC taken at diagnosis, and mALI was defined as L3MI x serum albumin/NLR. Using chi-squared test determined maximum cut-offs for low ALI and low mALI, the prognostic values of low ALI and low mALI were tested using Kaplan-Meier method and Cox proportional hazards analysis. Finally, deviance statistics was used to test whether the goodness of fit of the prognostic model is improved by adding mALI as an extra variable.

RESULTS

Patients with low ALI (cut-off, 31.1, n = 94) had shorter OS than patients with high ALI (median, 6.8 months vs. 15.8 months; p < 0.001), and patients with low mALI (cut-off 67.7, n = 94) had shorter OS than patients with high mALI (median, 6.8 months vs. 16.5 months; p < 0.001). There was no significant difference in estimates of median survival time between low ALI and low mALI (z = 0.000, p = 1.000) and between high ALI and high mALI (z = 0.330, p = 0.740). Multivariable analysis showed that low ALI was an independent prognostic factor for shorter OS (HR, 1.67, p = 0.004), along with advanced age (HR, 1.49, p = 0.045), extensive disease (HR, 2.27, p < 0.001), supportive care only (HR, 7.86, p < 0.001), and elevated LDH (HR, 1.45, p = 0.037). Furthermore, goodness of fit of this prognostic model was not significantly increased by adding mALI as an extra variable (LR difference = 2.220, p = 0.136).

CONCLUSION

The present study confirms mALI using CT-determined L3MI has no additional prognostic value beyond original ALI using BMI. ALI is a simple and useful prognostic indicator in SCLC.

摘要

背景

晚期肺癌炎症指数(ALI,体重指数[BMI]×血清白蛋白/中性粒细胞与淋巴细胞比值[NLR])已被证明可预测小细胞肺癌(SCLC)的总生存期(OS)。CT能够对骨骼肌进行量化,而BMI不能准确反映身体成分。本研究旨在评估使用CT测定的L3肌肉指数(L3MI,L3水平的肌肉面积/身高²)计算的改良ALI(mALI)相对于原始ALI的预后价值。

方法

利用186例连续的SCLC患者诊断时的CT图像计算L3MI,并将mALI定义为L3MI×血清白蛋白/NLR。使用卡方检验确定低ALI和低mALI的最大截断值,采用Kaplan-Meier法和Cox比例风险分析检验低ALI和低mALI的预后价值。最后,使用偏差统计检验将mALI作为额外变量添加后,预后模型的拟合优度是否得到改善。

结果

低ALI(截断值为31.1,n = 94)的患者OS短于高ALI的患者(中位数,6.8个月对15.8个月;p < 0.001),低mALI(截断值67.7,n = 94)的患者OS短于高mALI的患者(中位数,6.8个月对16.5个月;p < 0.001)。低ALI和低mALI之间(z = 0.000,p = 1.000)以及高ALI和高mALI之间(z = 0.330,p = 0.740)的中位生存时间估计无显著差异。多变量分析显示,低ALI是OS缩短的独立预后因素(HR,1.67,p = 0.004),此外还有高龄(HR,1.49,p = 0.045)、广泛期疾病(HR,2.27,p < 0.001)、仅接受支持治疗(HR,7.86,p < 0.001)和乳酸脱氢酶升高(HR,1.45,p = 0.037)。此外,将mALI作为额外变量添加后,该预后模型的拟合优度未显著提高(似然比差异 = 2.220,p = 0.136)。

结论

本研究证实,使用CT测定的L3MI计算的mALI相对于使用BMI计算的原始ALI并无额外的预后价值。ALI是SCLC中一个简单且有用的预后指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2daa/5051688/75770c1713c2/pone.0164056.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验